Ottobock grows H1 2026 core revenue 7.7% to EUR 818.5M and raises its margin target

Ottobock

Ottobock's first-half core revenue rose 7.7%, driven by prosthetics and neuro-orthotics, and its core margin rose to 25.3%. It also invested in interface maker Blue Arbor and agreed to buy electrical-stimulation firm Fesia.

• Underlying core EBITDA EUR 207.0M, up 18.1%.
• 2026 guidance: 6-8% organic growth, core margin above 27%.
• Signed to buy Fesia Technology on 7 July 2026; agreed to sell its wheelchair business.